TRPM7 and myeloid sarcoma: In conclusion, we show that TRPM7 is highly expressed in reactive astrocytes within MS lesions and that enhanced astrocytic TRPM7 levels impair neurite outgrowth by increased production of CSPGs, a key component of the gliotic scar.